Translate
Macrogenics, Inc.
About
4.46USD-0.06 -1.33%
Closed • Updated at 13:10 GMT+00:00Market Cap$283.49M
Volume836.4K
Beta0.70
RSI74.83
Gross Margin69.93%
Macrogenics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 14 2026
MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum
May 13 2026
MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation
May 11 2026
MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals
May 4 2026
MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
Apr 8 2026
FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study